PHF6 Gene

Summary

PHF6 (PHD Finger Protein 6), also known as BORCS2, is a gene located on the X chromosome that encodes a protein containing plant homeodomain (PHD) zinc finger motifs. This domain is commonly found in chromatin-binding proteins involved in epigenetic regulation and transcriptional control. PHF6 functions as an epigenetic reader, recognizing modified histone tails and recruiting chromatin-modifying complexes to specific genomic regions [1].

PHF6 is widely expressed in human tissues, with high expression in the brain, particularly during development. The protein localizes to the nucleus where it participates in transcriptional regulation. Studies have revealed associations between PHF6 variants and neurodevelopmental disorders, most notably Borjeson-Le syndrome, an X-linked disorder characterized by intellectual disability, developmental delay, characteristic facial features, and occasionally seizures [2]. The identification of PHF6 as the causative gene for Borjeson-Le syndrome provided important insights into the role of epigenetic regulation in neurodevelopment and cognitive function.

Normal Function

Protein Structure and Domains

The PHF6 protein contains several key structural features:

• PHD Zinc Finger Domains: Two PHD-type zinc fingers at the C-terminus that function as epigenetic reader modules

  • PHD1: N-terminal PHD domain involved in histone binding

  • PHD2: C-terminal PHD domain with similar function

• N-terminal Region: Contains regions of low complexity and potential regulatory sequences

• Nuclear Localization: The protein contains nuclear localization signals that target it to the nucleus

The PHD finger is a Cys4-His-Cys3-His-Cys (C3HC4) zinc finger domain that binds to histone modifications, particularly methylated lysine residues on histone H3. This allows PHF6 to function as a “reader” of the histone code, translating epigenetic marks into transcriptional outcomes.

Epigenetic Reader Function

PHF6 functions as an epigenetic reader through:

1. Histone Tail Recognition: The PHD domains bind to specific histone modifications, particularly:

   • H3K4me0 (unmethylated H3 lysine 4) — the “K4me0” mark associated with gene silencing

   • H3K9me3 — a repressive mark

   • Other modified histone tails depending on the specific PHD domain

2. Chromatin Complex Recruitment: By binding to modified histones, PHF6 recruits:

   • Histone deacetylases (HDACs) for gene repression

   • Chromatin remodeling complexes

   • Other epigenetic modifiers

3. Transcriptional Regulation: PHF6 influences:

   • Gene expression patterns during development

   • Cell type-specific transcriptional programs

   • Epigenetic maintenance of cellular identity

Subcellular Localization

• Nucleus: Predominantly nuclear, with enrichment in certain nuclear compartments

• Chromatin-associated: Direct association with chromatin

• Cell type variability: Localization patterns may vary across cell types

Brain Expression and Function

Developmental Expression

PHF6 shows dynamic expression during brain development:

• Embryonic Development: High expression in the developing forebrain

• Perinatal Period: Continued high expression during cortical development

• Adult Brain: Moderate expression, with higher levels in regions with ongoing plasticity

Regional Distribution

PHF6 is expressed throughout the brain with notable levels in:

• Cerebral Cortex: pyramidal neurons in all layers

• Hippocampus: CA regions and dentate gyrus

• Basal Ganglia: medium spiny neurons

• Cerebellum: Purkinje cells and granule cells

• Thalamus: various nuclei

Functions in the Brain

In the nervous system, PHF6 participates in:

1. Neurogenesis: Regulation of neural progenitor cell proliferation and differentiation

2. Cortical Development: Proper layering and connectivity of the cerebral cortex

3. Synaptic Function: Potential roles in synaptic plasticity and function

4. Neuronal Survival: Supporting neuronal viability during development

The widespread brain expression and critical role in development explain the profound neurodevelopmental phenotypes in PHF6-related disorders.

Disease Associations

Borjeson-Le Syndrome

Borjeson-Le syndrome (BLS) is an X-linked neurodevelopmental disorder caused by PHF6 mutations:

Clinical Features:

• Intellectual Disability: Moderate to severe ID in most patients

• Developmental Delay: Delayed milestones, particularly speech and motor

• Characteristic Facial Features:

  • Deep-set eyes

  • Large ears

  • Pointed chin

  • Thick lips

• Growth Abnormalities: Short stature, microcephaly in some patients

• Seizures: Approximately 50% of patients have seizures

• Hypotonia: Early-onset muscular hypotonia

• Autistic Features: Some patients show autism-like behaviors

• Speech Impairment: Delayed or absent speech

Genotype-Phenotype Correlation:

• Nonsense/frameshift mutations → more severe phenotype

• Missense mutations → variable severity

• Females (heterozygotes) may show milder features

X-Linked Intellectual Disability

Beyond Borjeson-Le syndrome, PHF6 variants contribute to X-linked ID:

• Non-syndromic XLID: Some PHF6 variants cause ID without the full BLS phenotype

• Female carriers: May manifest milder cognitive impairment

• Mutation types: Both truncating and missense variants implicated

Neurodevelopmental Implications

The mechanism of neurodevelopmental dysfunction:

1. Epigenetic Dysregulation: Loss of PHF6’s histone-reading function alters gene expression

2. Developmental Timing: Disrupted epigenetic regulation during critical developmental windows

3. Brain Region Specificity: Some brain regions more affected than others

4. Network Formation: Impaired formation of neural circuits

Genetic Variants

Mutation Spectrum

Mutation Distribution

• PHD Domain Clustering: Many pathogenic variants cluster in the PHD zinc finger domains

• De Novo Mutations: Many cases arise from de novo variants

• X-linked Inheritance: Primarily transmitted from carrier mothers

• Female Carriers: Usually asymptomatic but can manifest

Population Genetics

• Rare disorder: PHF6-related disease is very rare

• Founder effects: Some populations may have specific variants

• Carrier frequency: Extremely low in general populations

Molecular Mechanisms

Histone Binding

PHF6’s PHD domains bind to specific histone marks:

PHD Domain Specificity:

• PHD1 shows preference for H3K4me0 (unmethylated)

• PHD2 may recognize other modifications

• Binding affinity affected by surrounding amino acids

Functional Consequences:

• Recruitment of repressive complexes

• Positioning of nucleosomes

• Regulation of chromatin accessibility

Transcriptional Regulation

PHF6 influences transcription through:

1. Direct Binding: Associates with regulatory regions of target genes

2. Complex Formation: Partners with chromatin modifiers

3. Histone Modification: May influence local histone modifications

4. Long-range Effects: May affect distant enhancers and promoters

Target Genes

While specific targets are being characterized, PHF6 likely regulates:

• Genes involved in brain development

• Neurotransmitter-related genes

• Developmental transcription factors

• Ion channel genes

Animal Models

Mouse Models

Phf6 knockout mice demonstrate:

• Growth retardation: Reduced body size

• Neurological phenotypes: Altered behavior and motor function

• Cellular changes: Abnormal neuronal morphology

• Molecular alterations: Dysregulated gene expression

Zebrafish Models

Zebrafish morpholino knockdowns show:

• Developmental abnormalities

• Brain patterning defects

• Behavioral changes

Model Systems

Induced pluripotent stem cells (iPSCs) from patients:

• Show altered neuronal differentiation

• Display transcriptional dysregulation

• Provide disease modeling opportunities

Research Findings

Key Publications

1. Lower KM, et al. PHF6 mutations cause Borjeson-Le syndrome (2003)

2. Voss AK, et al. PHF6 in brain development (2014)

3. Liu J, et al. PHF6 epigenetic reader function (2015)

4. Baker K, et al. PHF6 and neurodevelopment (2015)

5. Zhang C, et al. PHF6 in transcriptional regulation (2016)

Research Directions

• Structural studies of PHD domain-histone interactions

• Identification of PHF6 target genes and pathways

• Development of therapeutic interventions

• Patient-derived cell models for drug screening

Interaction Network

PHF6 participates in chromatin-related signaling:

graph TD
    A["PHF6/BORCS2"] --> B["PHD Domains"]
    B --> C["Histone Binding"]
    C --> D["H3K4me0"]
    C --> E["H3K9me3"]
    D --> F["Repressive Complex"]
    E --> F
    F --> G["Chromatin Remodeling"]
    G --> H["Gene Silencing"]
    H --> I["Transcriptional Regulation"]
    I --> J["Development"]
    J --> K["Brain Development"]
    K --> L["Cognitive Function"]

Diagnostic Considerations

Genetic Testing

• Sequencing: Targeted PHF6 sequencing or gene panels

• MLPA: Detection of deletions/duplications

• Exome sequencing: Identification of novel variants

• X-inactivation studies: For carrier identification

Clinical Diagnosis

Based on:

• Characteristic facial features

• Intellectual disability

• Seizures (in ~50%)

• X-linked family pattern

• Confirmation by genetic testing

Differential Diagnosis

Other causes of X-linked ID to consider:

• RPS6KA3 (Coffin-Lowry syndrome)

• FMR1 (Fragile X syndrome)

• Other XLID genes

Therapeutic Approaches

Current Strategies

• Symptomatic treatment: Seizure control, developmental support

• Early intervention: Physical, occupational, speech therapy

• Educational support: Individualized education plans

• Family support: Genetic counseling

Experimental Approaches

• Epigenetic therapies: Targeting chromatin modifiers

• Gene therapy: Potential for future intervention

• Small molecules: Modulating PHF6 function

• Cell therapy: Stem cell-based approaches (preclinical)

See Also

• Genes Directory

• Proteins Directory

• Borjeson-Le Syndrome

• Intellectual disability

• X-linked intellectual disability

• Epigenetics

• Chromatin regulation

• Neurodevelopment

External Links

• NCBI Gene: PHF6

• OMIM: 300415

• Ensembl: ENSG00000156500

• UniProt: Q8IU60

• ClinVar: PHF6 variants